The PREPARED Case Study App for deep reflection on research ethics challenges during crises

IF 58.7 1区医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Nature Medicine Pub Date : 2025-03-14 DOI:10.1038/s41591-025-03549-2

Doris Schroeder, Nearchos Paspallis, Nicos Kasenides, Kate Chatfield, Carly Seedall, Michelle Singh

引用次数: 0

Abstract

Allegiance to the Hippocratic Oath was once considered sufficient to ensure ethical conduct in medicine and health care. But in today’s world, healthcare professionals face unprecedented ethical dilemmas¹, from navigating mandatory COVID-19 vaccinations to addressing systemic racism in clinical care². Simultaneously, the systematic practice of medical research has a history that spans only about 300 years³, which has left room for evolution in ethical standards and practices.

One response to the challenge of new ethical dilemmas is new ethics guidance. For instance, during the COVID-19 pandemic, hundreds of new ethics codes and guidance documents were issued around the world in English alone⁴.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Medicine 医学-生化与分子生物学

CiteScore

100.90

自引率

0.70%

发文量

525

审稿时长

1 months

期刊介绍： Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors. Nature Medicine consider all types of clinical research, including: -Case-reports and small case series -Clinical trials, whether phase 1, 2, 3 or 4 -Observational studies -Meta-analyses -Biomarker studies -Public and global health studies Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.